You are currently on the new version of our website. Access the old version .

Angiogenesis Inhibitors

Special Issue Information

Keywords

  • angiopoietin-2 antagonists
  • antiangiogenic monoclonal antibodies
  • assays to validate antiangiogenic agents
  • avastin
  • biomarkers of response to antiangiogenic therapy
  • combination of antiangiogenic therapy with other anticancer therapies
  • endogenous inhibitors of angiogenesis
  • genetic strategies for targeting angiogenesis
  • imaging of tumor angiogenesis
  • integrins as targets for antiangiogenic therapy
  • metronomic low-dose antiangiogenic chemotherapy
  • protein tyrosine kinase inhibitors
  • targeted drug delivery to the tumor neovasculature
  • thalidomide and its IMiD derivatives
  • translating angiogenesis inhibitors to the clinic

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247